At2g30620 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At2g30620 antibody; T06B20.3 antibody; Histone H1.2 antibody
Target Names
At2g30620
Uniprot No.

Target Background

Function
Histone H1 proteins play a crucial role in the compaction of nucleosome chains into higher-order chromatin structures.
Database Links

KEGG: ath:AT2G30620

STRING: 3702.AT2G30620.1

UniGene: At.20406

Protein Families
Histone H1/H5 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is the At2g30620 gene and its protein product in Arabidopsis thaliana?

At2g30620 encodes a protein in Arabidopsis thaliana (Mouse-ear cress), a model organism widely used in plant molecular biology research. This gene is associated with specific protein products that researchers can study using antibodies such as the commercially available At2g30620 Antibody (product code CSB-PA010378XA01DOA, Uniprot number P26569) . Understanding the function and characteristics of this protein requires specific antibody-based detection methods in combination with other molecular biology techniques. The protein belongs to the chromatin-associated proteins family, which plays important roles in nuclear organization and gene expression regulation in plants. Researchers studying this protein typically investigate its role in plant development, stress responses, or other cellular processes.

How do I determine if the At2g30620 antibody is suitable for my specific Arabidopsis research application?

Determining antibody suitability requires evaluation of several technical parameters before commencing your experiments. First, review available validation data for the specific At2g30620 antibody product (like CSB-PA010378XA01DOA) to confirm it has been tested in applications relevant to your research (immunofluorescence, Western blotting, ChIP, etc.). Second, assess cross-reactivity profiles, particularly if you're working with multiple Arabidopsis proteins or comparing different plant species. Third, examine epitope information to ensure the antibody recognizes your protein region of interest. Fourth, evaluate published literature where researchers have successfully used this antibody in applications similar to yours. Finally, consider performing preliminary validation experiments such as Western blots with positive and negative controls to confirm specificity before proceeding with more complex or time-consuming experiments.

What are the recommended fixation and sample preparation methods when using At2g30620 antibody for immunolocalization in Arabidopsis tissues?

For successful immunolocalization using At2g30620 antibody in Arabidopsis tissues, proper fixation and sample preparation are critical. Based on established protocols for nuclear proteins in Arabidopsis, fixation with 4% paraformaldehyde in PBS for 20-30 minutes at room temperature helps preserve protein epitopes while maintaining cellular structure. For visualization of subcellular localization patterns, counterstaining chromosomal DNA with 4′,6-diamidino-2-phenylindole (DAPI) is recommended, as this approach has proven effective for studying nuclear proteins in Arabidopsis . When preparing samples, consider tissue-specific expression patterns of At2g30620, as expression levels may vary across different plant tissues or developmental stages. For optimal results, permeabilization steps should be carefully optimized, typically using 0.1-0.5% Triton X-100 to allow antibody access to nuclear targets while preserving cellular morphology. Multiple washing steps with PBS containing 0.1% Tween-20 will help reduce background signal and improve detection specificity.

How can I distinguish between specific and non-specific binding when using At2g30620 antibody in chromatin immunoprecipitation (ChIP) experiments?

Distinguishing between specific and non-specific binding in ChIP experiments with At2g30620 antibody requires rigorous controls and validation steps. First, always include a preimmune serum control processed identically to your experimental samples, as preimmune sera typically do not result in specific immunostaining patterns . Second, implement input controls (chromatin before immunoprecipitation) and mock IP controls (using non-relevant antibodies of the same isotype) to establish background signal levels. Third, validate ChIP efficiency using quantitative PCR of known targets versus non-target regions. Fourth, consider performing sequential ChIP (re-ChIP) to confirm co-occupancy with other chromatin-associated factors if relevant to your research question. Fifth, analyze enrichment patterns across multiple biological replicates to identify consistent versus variable signals. Finally, confirm specificity through alternative approaches such as ChIP followed by mass spectrometry or comparing results with tagged protein versions. These comprehensive validation strategies will strengthen the reliability of your At2g30620 ChIP data and enable confident interpretation of genomic binding patterns.

What are the current hypotheses regarding the cell cycle-dependent localization patterns of At2g30620 protein, and how can antibody-based approaches help test these hypotheses?

Current hypotheses regarding cell cycle-dependent localization of nuclear proteins like At2g30620 center around their dynamic association with chromatin during different cell cycle phases. Similar to other chromatin-associated proteins in Arabidopsis, At2g30620 may exhibit a speckled distribution pattern in interphase nuclei, being detected in both euchromatin and heterochromatic chromocenters, but potentially showing altered distribution during mitosis . Research with related chromatin proteins has revealed that in mitotic cells, condensed chromosomes often show reduced immunoreactivity with specific antibodies, suggesting these proteins may dissociate from chromatin during division . To test these hypotheses, researchers can employ multi-color immunofluorescence approaches combining At2g30620 antibody with cell cycle markers such as antibodies against histone H3 phosphorylated at Ser-28, which provides cell cycle-specific immunosignals and confirms accessibility of dividing cells to antibodies . Time-course experiments capturing different cell cycle stages, combined with super-resolution microscopy, can further elucidate the precise temporal dynamics of At2g30620 chromatin association and dissociation during cell division.

How do mutations in the nuclear localization signal (NLS) of At2g30620 affect its cellular distribution, and how can antibody detection methods quantify these effects?

Mutations in nuclear localization signals (NLSs) can dramatically alter cellular distribution of proteins like At2g30620. Research on similar chromatin-associated proteins in Arabidopsis has demonstrated that specific amino acid residues within NLS regions are critical for proper nuclear targeting. For instance, mutation of key arginine residues to glycine in the context of full-length proteins can result in loss of nuclear accumulation, causing the mutated proteins to be detected in both cytosol and nucleus rather than exclusively in the nucleus . To quantify these effects, immunofluorescence approaches using At2g30620 antibody combined with high-content imaging analysis provide robust quantitative data on nuclear versus cytoplasmic distribution ratios. Additionally, cellular fractionation followed by Western blot analysis with At2g30620 antibody enables biochemical quantification of protein distribution between nuclear and cytoplasmic compartments. For more precise analysis, researchers can employ fluorescence recovery after photobleaching (FRAP) experiments with GFP-tagged wild-type versus NLS-mutated At2g30620 proteins, complemented by immunostaining with At2g30620 antibody to confirm patterns observed with tagged constructs match those of the endogenous protein.

What are the optimal conditions for using At2g30620 antibody in Western blot applications with Arabidopsis protein extracts?

For optimal Western blot results with At2g30620 antibody, several critical parameters must be carefully optimized. First, protein extraction should be performed using extraction buffers containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, and protease inhibitor cocktail, which effectively preserves nuclear proteins while minimizing degradation. Second, protein concentration should be determined using Bradford or BCA assays, loading 20-40μg total protein per lane for whole-cell extracts, or 10-20μg for nuclear-enriched fractions. Third, use freshly prepared SDS-PAGE gels (10-12% acrylamide) for optimal separation of the target protein. Fourth, transfer proteins to PVDF membranes (rather than nitrocellulose) using semi-dry transfer at 15V for 30-45 minutes to ensure efficient transfer of nuclear proteins. Fifth, block membranes with 5% non-fat dry milk in TBST for 1 hour at room temperature before applying At2g30620 antibody at 1:1000 dilution overnight at 4°C. Sixth, after thorough washing, apply HRP-conjugated secondary antibody at 1:5000 dilution for 1 hour at room temperature. Finally, visualize using enhanced chemiluminescence with exposure times optimized based on signal intensity. This protocol has been successfully applied to similar chromatin-associated proteins in Arabidopsis and should provide specific detection of At2g30620 protein.

How can I troubleshoot weak or absent signals when using At2g30620 antibody in immunofluorescence experiments with Arabidopsis tissues?

Troubleshooting weak or absent signals in immunofluorescence experiments requires systematic evaluation of each experimental step. First, verify antibody functionality through Western blot analysis, which can confirm if the At2g30620 antibody recognizes the target protein in your samples. Second, optimize fixation conditions, as overfixation can mask epitopes while underfixation may not preserve cellular structures; test both paraformaldehyde (2-4%) and methanol-based fixation protocols. Third, enhance permeabilization by extending Triton X-100 treatment time or increasing concentration (0.1-0.5%), as nuclear envelope may restrict antibody access to chromatin-associated proteins. Fourth, implement antigen retrieval techniques such as citrate buffer treatment (pH 6.0, 95°C for 10-20 minutes) which can expose hidden epitopes. Fifth, reduce background by extending blocking time (2-3 hours) with higher BSA concentration (3-5%) and adding 0.1% Tween-20 to all wash steps. Sixth, increase antibody concentration or incubation time (1:100 dilution, overnight at 4°C). Seventh, switch to high-sensitivity detection systems such as tyramide signal amplification. Finally, confirm tissue viability and protein expression by using positive control antibodies targeting abundant nuclear proteins like histones, which should give strong nuclear staining patterns if the sample preparation is adequate .

What controls should be included when validating a new batch of At2g30620 antibody for research applications?

Comprehensive validation of new At2g30620 antibody batches requires multiple controls to ensure experimental reliability. First, perform side-by-side comparison with previous antibody batches on identical samples to detect any sensitivity or specificity differences. Second, include preimmune serum controls which should not produce specific immunostaining patterns in contrast to the specific nuclear labeling pattern expected with anti-At2g30620 sera . Third, implement blocking experiments by pre-incubating the antibody with excess immunizing peptide/protein, which should abolish specific signals if the antibody is truly specific. Fourth, test knockdown/knockout samples where available, as tissues from At2g30620 knockout plants should show significantly reduced or absent signals compared to wild-type. Fifth, evaluate cross-reactivity against related proteins using recombinant protein arrays or extracts from heterologous expression systems. Sixth, perform dual-labeling with antibodies against known interaction partners to confirm expected co-localization patterns. Seventh, validate across multiple applications (Western blot, immunoprecipitation, ChIP, immunofluorescence) to ensure consistent performance across techniques. These comprehensive validation steps ensure that experimental data generated with the new antibody batch will be reliable and reproducible across different research applications.

How can At2g30620 antibody be used to investigate protein-protein interactions in chromatin regulation networks?

At2g30620 antibody offers multiple approaches for investigating protein-protein interactions within chromatin regulation networks. Co-immunoprecipitation (Co-IP) represents the primary method, where At2g30620 antibody is used to pull down the target protein along with its interaction partners from Arabidopsis nuclear extracts, followed by mass spectrometry analysis to identify the complete interactome. Proximity ligation assays (PLA) provide an alternative approach, combining At2g30620 antibody with antibodies against suspected interaction partners to visualize protein complexes directly within cellular contexts as fluorescent spots when proteins are within 40nm proximity. ChIP-reChIP techniques, using sequential immunoprecipitation with At2g30620 antibody followed by antibodies against other chromatin factors, can identify co-occupancy at specific genomic loci. Bimolecular fluorescence complementation (BiFC) validation, while not directly using the antibody, can confirm interactions identified by antibody-based methods through expression of fusion proteins in plant cells. For dynamic interaction studies, fluorescence resonance energy transfer (FRET) combined with immunostaining can reveal spatial and temporal aspects of protein complex formation. These approaches collectively enable comprehensive mapping of At2g30620's role within chromatin regulatory networks and help establish functional relationships between different nuclear factors in Arabidopsis.

How can confocal microscopy and At2g30620 antibody be combined to analyze the spatial organization of chromatin in Arabidopsis nuclei?

Confocal microscopy combined with At2g30620 antibody immunolocalization provides powerful insights into chromatin spatial organization in Arabidopsis nuclei. This approach enables three-dimensional visualization of At2g30620 protein distribution relative to other nuclear landmarks. For optimal results, implement a multi-staining protocol combining At2g30620 antibody immunofluorescence with DAPI counterstaining for DNA and additional markers for nuclear compartments . Z-stack acquisition at 0.2-0.3μm intervals through entire nuclei provides complete spatial information that can be reconstructed into 3D models using software like ImageJ/Fiji with the 3D Viewer plugin. For quantitative analysis, measure fluorescence intensity distribution using line scan profiles across nuclei to determine whether At2g30620 shows preferential association with euchromatin or heterochromatin regions. Co-localization analysis with markers for specific chromatin states (like H3K9me2 for heterochromatin) can be quantified using Pearson's or Mander's coefficients. For dynamic studies, combine with live-cell imaging of fluorescently tagged chromatin components complemented by correlative light and electron microscopy (CLEM) for nanoscale contextual information. Super-resolution techniques like structured illumination microscopy (SIM) or stochastic optical reconstruction microscopy (STORM) can further resolve fine-scale distribution patterns beyond the diffraction limit, revealing how At2g30620 contributes to chromatin domain organization in Arabidopsis nuclei.

How does the subcellular localization pattern of At2g30620 compare with other chromatin-associated proteins in Arabidopsis thaliana?

At2g30620 protein likely exhibits subcellular localization patterns similar to other chromatin-associated proteins in Arabidopsis thaliana. Research on related chromatin proteins such as HMGA and HMGB shows they typically display a speckled distribution pattern in interphase nuclei and can be detected in both euchromatin regions and heterochromatic chromocenters . This pattern is characteristic of proteins involved in chromatin organization and transcriptional regulation. Interestingly, during mitosis, many chromatin-associated proteins including HMGA and HMGB1 show diminished association with condensed chromosomes, resulting in diffuse cytosolic staining rather than chromosome-associated signals . This dynamic redistribution reflects cell cycle-dependent functions of these proteins. The nuclear localization of At2g30620, like other chromatin proteins, is likely mediated by specific nuclear localization signals (NLSs) that interact with nuclear import machinery. Mutations in these NLS regions, particularly in key arginine residues, can disrupt proper nuclear targeting, resulting in cytoplasmic mislocalization similar to that observed with GFP alone rather than the specific nuclear accumulation seen with intact NLS sequences . When studying At2g30620 localization, comparing its pattern with well-characterized proteins such as histone H1.2 provides valuable context, as H1.2 shows consistent nuclear localization that serves as a reliable reference point for nuclear targeting efficiency.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.